A critical European view of the HERS trial

Maturitas. 1998 Nov 30;31(1):15-9. doi: 10.1016/s0378-5122(98)00103-0.
No abstract available

Publication types

  • Review

MeSH terms

  • Coronary Disease / prevention & control*
  • Estrogen Replacement Therapy*
  • Estrogens, Conjugated (USP) / adverse effects
  • Estrogens, Conjugated (USP) / therapeutic use*
  • Europe
  • Female
  • Humans
  • Progestins / therapeutic use*
  • Randomized Controlled Trials as Topic
  • United States
  • Women's Health*

Substances

  • Estrogens, Conjugated (USP)
  • Progestins